BlackRock Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $214M | Sell |
1,751,063
-535,828
| -23% | -$65.6M | 0.22% | 106 |
|
|
2016
Q3 | $280M | Buy |
2,286,891
+1,295,520
| +131% | +$159M | 0.29% | 83 |
|
|
2016
Q2 | $116M | Sell |
991,371
-27,413
| -3% | -$3.2M | 0.12% | 182 |
|
|
2016
Q1 | $142M | Sell |
1,018,784
-302,034
| -23% | -$42M | 0.15% | 152 |
|
|
2015
Q4 | $252M | Sell |
1,320,818
-182,608
| -12% | -$34.8M | 0.27% | 90 |
|
|
2015
Q3 | $235M | Buy |
1,503,426
+157,434
| +12% | +$24.6M | 0.25% | 98 |
|
|
2015
Q2 | $243M | Buy |
1,345,992
+181,251
| +16% | +$32.8M | 0.25% | 104 |
|
|
2015
Q1 | $202M | Sell |
1,164,741
-100,701
| -8% | -$17.5M | 0.21% | 121 |
|
|
2014
Q4 | $234M | Sell |
1,265,442
-89,970
| -7% | -$16.6M | 0.24% | 111 |
|
|
2014
Q3 | $225M | Sell |
1,355,412
-49,437
| -4% | -$8.2M | 0.22% | 110 |
|
|
2014
Q2 | $220M | Buy |
1,404,849
+238,442
| +20% | +$37.3M | 0.21% | 118 |
|
|
2014
Q1 | $177M | Buy |
1,166,407
+535,161
| +85% | +$81.4M | 0.17% | 142 |
|
|
2013
Q4 | $83.9M | Buy |
631,246
+234,371
| +59% | +$31.1M | 0.08% | 244 |
|
|
2013
Q3 | $46.1M | Sell |
396,875
-811,517
| -67% | -$94.3M | 0.05% | 334 |
|
|
2013
Q2 | $111M | Buy |
+1,208,392
| New | +$111M | 0.12% | 187 |
|